IL134935A0 - Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase - Google Patents

Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Info

Publication number
IL134935A0
IL134935A0 IL13493598A IL13493598A IL134935A0 IL 134935 A0 IL134935 A0 IL 134935A0 IL 13493598 A IL13493598 A IL 13493598A IL 13493598 A IL13493598 A IL 13493598A IL 134935 A0 IL134935 A0 IL 134935A0
Authority
IL
Israel
Prior art keywords
inhibitors
neutrophil elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
IL13493598A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL134935A0 publication Critical patent/IL134935A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
IL13493598A 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase IL134935A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9719187.8A GB9719187D0 (en) 1997-09-09 1997-09-09 Compounds
PCT/EP1998/005604 WO1999012931A1 (fr) 1997-09-09 1998-09-07 Derives de pyrrolopyrrolone en tant qu'inhibiteurs de neutrophile elastase

Publications (1)

Publication Number Publication Date
IL134935A0 true IL134935A0 (en) 2001-05-20

Family

ID=10818820

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13493598A IL134935A0 (en) 1997-09-09 1998-09-07 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Country Status (24)

Country Link
US (1) US6228853B1 (fr)
EP (1) EP1019406A1 (fr)
JP (1) JP2001515902A (fr)
KR (1) KR20010023830A (fr)
CN (1) CN1278821A (fr)
AP (1) AP2000001760A0 (fr)
AU (1) AU9536098A (fr)
BR (1) BR9811651A (fr)
CA (1) CA2303249A1 (fr)
EA (1) EA200000205A1 (fr)
EE (1) EE200000137A (fr)
GB (1) GB9719187D0 (fr)
HR (1) HRP20000136A2 (fr)
HU (1) HUP0003475A3 (fr)
ID (1) ID24364A (fr)
IL (1) IL134935A0 (fr)
IS (1) IS5394A (fr)
MA (1) MA26544A1 (fr)
NO (1) NO20001200L (fr)
PL (1) PL339186A1 (fr)
SK (1) SK3242000A3 (fr)
TR (1) TR200001026T2 (fr)
WO (1) WO1999012931A1 (fr)
ZA (1) ZA988162B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805818B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
US7745226B2 (en) * 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
US7972868B2 (en) 2007-11-28 2011-07-05 Quest Diagnostics Investments Incorporated Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
US7977117B2 (en) 2009-12-03 2011-07-12 Quest Diagnostics Investments Incorprated Vitamin D metabolite determination utilizing mass spectrometry following derivatization
JP5739903B2 (ja) 2009-12-11 2015-06-24 クエスト ダイアグノスティックス インヴェストメンツ インコーポレイテッド 複合試料中のステロイド化合物の質量分析
CN102753964A (zh) 2009-12-11 2012-10-24 奎斯特诊断投资公司 非衍生的、非代谢的维生素d的质谱测定
AU2020349353A1 (en) 2019-09-17 2022-04-14 Duke University Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
HUE064089T2 (hu) 2020-04-16 2024-02-28 Mereo Biopharma 4 Ltd Alvelesztat neutrofil elasztáz inhibitort alkalmazó módszerek alfa-1-antitripszin hiány által közvetített légzõszervi megbetegedés kezelésére
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983245A (en) 1975-02-06 1976-09-28 Smithkline Corporation Certain 4-(3-azacycloalkoxy or azacycloalkylmethoxy)benzoylbenzofurans or benzothiophenes
GB8512230D0 (en) * 1985-05-14 1985-06-19 Shell Internationale Researche Preparation of carboxylic acid salt
GB9211783D0 (en) 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US6020368A (en) * 1996-01-03 2000-02-01 Hinks; Jeremy David Carbamoyloxy derivatives of mutiline and their use as antibacterials
IL125859A0 (en) 1996-03-28 1999-04-11 Glaxo Group Ltd Pyrrolopyrrolone derivatives useful as inhibitors of neutrophil elastase

Also Published As

Publication number Publication date
NO20001200D0 (no) 2000-03-08
MA26544A1 (fr) 2004-12-20
HRP20000136A2 (en) 2000-08-31
JP2001515902A (ja) 2001-09-25
US6228853B1 (en) 2001-05-08
CN1278821A (zh) 2001-01-03
CA2303249A1 (fr) 1999-03-18
ID24364A (id) 2000-07-13
EA200000205A1 (ru) 2000-10-30
NO20001200L (no) 2000-05-08
EE200000137A (et) 2001-02-15
BR9811651A (pt) 2000-08-08
KR20010023830A (ko) 2001-03-26
WO1999012931A1 (fr) 1999-03-18
PL339186A1 (en) 2000-12-04
AU9536098A (en) 1999-03-29
EP1019406A1 (fr) 2000-07-19
ZA988162B (en) 2000-03-22
IS5394A (is) 2000-03-03
AP2000001760A0 (en) 2000-03-31
SK3242000A3 (en) 2001-03-12
HUP0003475A3 (en) 2002-01-28
TR200001026T2 (tr) 2000-09-21
HUP0003475A2 (hu) 2001-09-28
GB9719187D0 (en) 1997-11-12

Similar Documents

Publication Publication Date Title
IL125859A0 (en) Pyrrolopyrrolone derivatives useful as inhibitors of neutrophil elastase
IL141445A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
EP1004669A4 (fr) Nouvel inhibiteur de differentiation
PL339551A1 (en) Derivatives of rezorcin
SI1174431T1 (sl) 2-fenil-substituirani imidazotriazinoni kot inhibitorji fosfodiesteraze
PL333918A1 (en) Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors
HUP0103349A3 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
PL337773A1 (en) Derivatives of benzimidazoles
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
EG23756A (en) D-proline derivatives
AU3935895A (en) Alpha-ketoamide derivatives as cathepsin l inhibitor
IL134791A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
AU2274299A (en) Benzazine derivatives phosphodiesterase 4 inhibitors
HUP9801991A3 (en) Proline derivatives useful as inhibitors of human leukocyte elastase
IL139490A0 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
IL141446A0 (en) Benzazine derivatives as phosphodiesterase 4 inhibitors
HUP0003475A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
PL334769A1 (en) Derivatives of 5-aroylnaphtene
PL337875A1 (en) Derivatives of 6-azauracil as il-5 inhibitors
ZA985064B (en) Derivatives of pentaerythrits
ZA988160B (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
PL328221A1 (en) Novel derivatives of urea
ID23866A (id) Komposisi untuk menyelamatkan beras terhadap asetoklor
PL338777A1 (en) Derivative of piperidinylmethyloxazolydinone
SI0891362T1 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase